Percutaneous Left Ventricular Assist Devices: Clinical Uses, Future Applications, and Anesthetic Considerations

Pulido, Juan N.; Rihal, Charanjit S.

doi:10.1053/j.jvca.2009.10.026

Cited by 23 publications

(8 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Экстракорпоральная мембранная оксигенация (ЭКМО) -одна из самых первых и широко используемых методик механической циркуляторной поддержки при кардиогенном шоке [166]. Показаниями к установке ЭКМО становятся невозможность отключения от ИК, жизнеугрожающая сердечная недостаточность вследствие инфаркта миокарда или фульминантного миокардита и необходимость в дополнительной поддержке кровообращения при сердечно-легочной реанимации [167]. В настоящее время отсутствует информация по рандомизированным исследованиям на тему применения ЭКМО при сердечной недостаточности [168].…”

Section: вено-артериальная экстракорпоральная мембранная оксигенацияunclassified

Low cardiac output syndrome in cardiac surgery

et al. 2019

View full text Add to dashboard Cite

Ефремов Сергей Михайловичд-р мед. наук, врач анестезиологреаниматолог отделения реанимации и интенсивной терапии 1 ; ORCID: http:// orcid.org/0000-0001-5581-9169 Киров Михаил Юрьевич-д-р мед. наук, профессор, заведующий кафедрой анестезиологии и реаниматологии 2 ; ORCID: http://orcid.org/0000-0002-4375-3374 Ломиворотов Владимир Николаевич-д-р мед. наук, профессор учебного центра 1

show abstract

Section: вено-артериальная экстракорпоральная мембранная оксигенацияunclassified

Low cardiac output syndrome in cardiac surgery

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Perkutane Herzunterstützungssys-teme, wie Impella  und TandemHeart™, können im Rahmen der Akutther apie eines kardiogenen Schocks eingesetzt werden, wenn die medikamentöse oder mechanische Unterstützung mittels intraaortale Ballonpumpe (IABP) unzureichend ist. Außerdem finden sie prophylaktische Anwendung bei komplexen interventionellen Eingriffen am Herzen, wie etwa bei Koronarinterventionen bei Hochrisikopatienten oder bei Radiofrequenzablationen bei ventrikulären Arrhythmien [46]. Da …”

Section: Ventrikuläre Unterstützungssystemeunclassified

Nahinfrarotspektroskopie unter kardiopulmonaler Reanimation und mechanischer Kreislaufunterstützung

Wally

Velik‐Salchner

2015

Med Klin Intensivmed Notfmed

View full text Add to dashboard Cite

NIRS is a rapidly available, user-friendly, and noninvasive method for continuous measurement of rSO2. NIRS provides additional information about tissue oxygenation especially during resuscitation and extracorporeal circulatory assist support. Recommendations concerning the use of NIRS for standard monitoring during resuscitation and mechanical circulatory support are not currently available. Further studies are required to show if use of NIRS can reduce pulse control and hands-off times during resuscitation and if use of NIRS can improve outcome after CPR and mechanical circulatory support.

show abstract

“…The balloon, with a volume of 30 -50 cm 3 , inflates during diastole to augment diastolic arterial pressure with minimal impact on the systolic and mean arterial pressure. 16,17 As the device is gated to trigger in diastole with the QRS, its use is limited during rapid VTs and offers modest hemodynamic support.…”

Section: Percutaneous Support Optionsmentioning

confidence: 99%

The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation

Bunch

Mahapatra²,

Reddy

et al. 2012

Europace

View full text Add to dashboard Cite

Ventricular tachycardia (VT) is a common but serious arrhythmia that significantly adds to the morbidity and mortality of patients with structural heart disease. Percutaneous catheter ablation has evolved to be standard therapy to prevent recurrent implantable cardioverter defibrillator shocks from VT in patients on antiarrhythmia medications. Procedural outcomes in patients with structural heart disease are often limited by haemodynamically unstable VT. Although substrate- and pace-mapping techniques have become increasingly popular for VT ablation, these approaches can often times may not address inducible clinical and non-clinical VTs. Activation and entrainment mapping can help the operator target VT exit sites in a precise fashion minimizing the amount of radiofrequency ablation needed for a successful ablation. An evolving alternative strategy that allows induction and mapping of VT in the setting of severe cardiomyopathy and haemodynamic instability is through maintaining perfusion with a percutaneous ventricular assist device (pVAD). This review will discuss these pVAD technologies, distinguish technical applications of use, highlight the published clinical experience, provide a clinical approach for support device selection, and discuss use of these technologies with current mapping and navigational systems.

show abstract

Percutaneous Left Ventricular Assist Devices: Clinical Uses, Future Applications, and Anesthetic Considerations

Cited by 23 publications

References 35 publications

Low cardiac output syndrome in cardiac surgery

Low cardiac output syndrome in cardiac surgery

Nahinfrarotspektroskopie unter kardiopulmonaler Reanimation und mechanischer Kreislaufunterstützung

The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation

Contact Info

Product

Resources

About